KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Friday, 26th Apr 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0650 $0.110
52 weeks $0.0600 $1.31

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
Apr 26, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 25, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 24, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 23, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 22, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 19, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 18, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 17, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 16, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 15, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 12, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 11, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 10, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 09, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 08, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 05, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 04, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 03, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 02, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Apr 01, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Mar 28, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Mar 27, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Mar 26, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Mar 25, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Mar 22, 2024 $0.0748 $0.0748 $0.0748 $0.0748 0
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT